Author

Peter A. Morawski

Benaroya Research InstituteORCID 0000-0001-9159-4032Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Organism:human· 4 Research Focus:differential expression· 3 Approach:experimental assay· 3 Assay:bulk RNA-seq· 2 Approach:benchmark study· 1 Research Focus:chromatin & epigenetic regulation· 1 Assay:flow cytometry· 1

Frequent Co-Authors

Daniel J. CampbelliD· 4 shared Hannah A. DeBergiD· 3 shared Jeffrey S. CarliniD· 2 shared Mitchell L. FahningiD· 2 shared Aayush GuptaiD· 1 shared Alex HuiD· 1 shared Andreea M. BujoriD· 1 shared Anna C. BelkinaiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersImmunology

Daniel J. CampbellORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Homeostatic fibroblast niche collapse in clinically uninvolved skin marks a pre-fibrotic stage of systemic sclerosis

Alex Hu, Lin Wei Tung, Thomas Pulliam, Cory L Simpson, Sandra Lord, Jeffrey S Carlin, Hannah A DeBerg, Daniel J Campbell, Peter J Morawski

The paper identifies a pre-fibrotic stage in scleroderma by analyzing spatial transcriptomic changes in clinically uninvolved skin, showing early reprogramming of fibroblasts and vascular smooth muscle cells.

bioRxiv · Nov 6, 2026 · PreprintImmunology

Establishing an ex vivo platform for molecular profiling of skin structural cells using frozen human skin biopsies

Ayako Takamori, Hanna DeBerg, Peter Morawski, Mitch Fahning, James D Schlenker, William P Schmitt, Iris K Gratz, Daniel J Campbell

This study establishes a scalable ex vivo platform using frozen human skin biopsies to study inflammatory responses in skin structural cells.

bioRxiv · Nov 6, 2026 · PreprintImmunology

The altered T cell landscape in Systemic Sclerosis patients is characterized by dysfunctional type 1 immunity.

Victoria Volfson-Sedletsky, Hannah A. DeBerg, Mitchell L. Fahning, Ian R. Rifkin, Andreea M. Bujor, Daniel Campbell, Peter A. Morawski, Anna C. Belkina, Hans Dooms

This study identifies dysfunctional type 1 immunity in SSc patients through altered T cell subsets and reduced IFN-γ production.

bioRxiv · Dec 13, 2025 · PreprintImmunology

T cells promote distinct transcriptional programs of cutaneous inflammatory disease in keratinocytes and dermal fibroblasts

Hannah A. DeBerg, Mitchell L. Fahning, Suraj R. Varkhande, James D. Schlenker, William P. Schmitt, Aayush Gupta, Archana Kumari Singh, Iris Karina Gratz, Jeffrey S. Carlin, Daniel J. Campbell, Peter A. Morawski

The paper shows how different T cell types drive distinct transcriptional changes in skin cells during inflammation, linking these changes to diseases like psoriasis and scleroderma.

Journal of Investigative Dermatology · Apr 9, 2025Peer-reviewedImmunology